Cargando…
Basic Science with Preclinical Models to Investigate and Develop Liquid Biopsy: What Are the Available Data and Is It a Fruitful Approach?
The molecular analysis of circulating analytes (circulating tumor-DNA (ctDNA), -cells (CTCs) and -RNA (ctRNA)/exosomes) deriving from solid tumors and detected in the bloodstream—referred as liquid biopsy—has emerged as one of the most promising concepts in cancer management. Compelling data have ev...
Autores principales: | Cena, Benedetta, Melloul, Emmanuel, Demartines, Nicolas, Dormond, Olivier, Labgaa, Ismail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141279/ https://www.ncbi.nlm.nih.gov/pubmed/35628154 http://dx.doi.org/10.3390/ijms23105343 |
Ejemplares similares
-
The Role of Liquid Biopsy in Hepatocellular Carcinoma Prognostication
por: Labgaa, Ismail, et al.
Publicado: (2021) -
Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?
por: Gonvers, Stéphanie, et al.
Publicado: (2022) -
Experimental Models of Liquid Biopsy in Hepatocellular Carcinoma Reveal Clone‐Dependent Release of Circulating Tumor DNA
por: Labgaa, Ismail, et al.
Publicado: (2021) -
Carcinogenic effect of arsenic in digestive cancers: a systematic review
por: Kasmi, Sophie, et al.
Publicado: (2023) -
Machine learning to predict postoperative complications after digestive surgery: a scoping review
por: Ravenel, Maximilien, et al.
Publicado: (2023)